Association rate constants rationalise the pharmacodynamics of apixaban and rivaroxaban
about
Evaluating coagulation tests in patients with atrial fibrillation using direct oral anticoagulants.Influence of apixaban on commonly used coagulation assays: results from the Belgian national External Quality Assessment Scheme.Impact of four direct oral anticoagulants on rotational thromboelastometry (ROTEM).
P2860
Association rate constants rationalise the pharmacodynamics of apixaban and rivaroxaban
description
im März 2015 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 12 March 2015
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2015
@uk
name
Association rate constants rationalise the pharmacodynamics of apixaban and rivaroxaban
@en
Association rate constants rationalise the pharmacodynamics of apixaban and rivaroxaban
@nl
type
label
Association rate constants rationalise the pharmacodynamics of apixaban and rivaroxaban
@en
Association rate constants rationalise the pharmacodynamics of apixaban and rivaroxaban
@nl
prefLabel
Association rate constants rationalise the pharmacodynamics of apixaban and rivaroxaban
@en
Association rate constants rationalise the pharmacodynamics of apixaban and rivaroxaban
@nl
P2093
P50
P356
P1476
Association rate constants rationalise the pharmacodynamics of apixaban and rivaroxaban
@en
P2093
Charles-Marc Samama
Isabelle Gouin-Thibault
Jean-Louis Golmard
Virginie Siguret
P356
10.1160/TH14-10-0877
P577
2015-03-12T00:00:00Z